Job title: Acting Clinical Team Leader, Division of Gastroenterology & Inborn Errors Products
Frank Anania is a hepatologist who is currently a medical reviewer in the Division of Gastroenterology and Inborn Errors Products (DGIEP) in the Office of New Drugs of the US Food and Drug Administration. Prior to joining the Agency in early 2018, Anania was a physician-scientist who conducted basic biomedical research for several decades in the area of hepatic fibrosis and non-alcoholic fatty liver disease.
Regulatory Guidance for NASH with Compensated Cirrhosis 9:00 am
day: Day Two